» Articles » PMID: 14623199

Efficacy of Azithromycin for the Treatment of Feline Chlamydophilosis

Overview
Date 2003 Nov 19
PMID 14623199
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The current recommended treatment for feline chlamydophilosis involves daily oral administration of antimicrobials to all cats within an affected group for a prolonged period of time (4-6 weeks). Not surprisingly, owner compliance can be poor resulting in apparent treatment failure. Recent anecdotal evidence, supported by its efficacy in the treatment of Chlamydia trachomatis infection in humans, has suggested that azithromycin may offer an alternative by allowing less frequent dosing for a shorter duration. A clinical trial was designed to evaluate the efficacy of azithromycin for the treatment of chlamydia (Chlamydophila felis) infection in cats. Whilst azithromycin, given at 10-15 mg/kg daily for 3 days and then twice weekly, provided a similar, rapid resolution of clinical signs and negative isolation scores as doxycycline, C felis was re-isolated in four out of the five cats treated. Furthermore, even daily administration of azithromycin to chronically infected cats was ineffective in clearing infection. The azithromycin protocols used here were therefore found to be unsuccessful in eliminating the carriage of this strain of C felis.

Citing Articles

Doxycycline with or without famciclovir for infectious ophthalmic and respiratory disease: a prospective, randomized, masked, placebo-controlled trial in 373 kittens.

Vernau K, Kim S, Thomasy S, Lucyshyn D, Purpura J, Montgomery E J Feline Med Surg. 2024; 26(11):1098612X241278413.

PMID: 39485362 PMC: 11531040. DOI: 10.1177/1098612X241278413.


Pathological and pharmacovigilance monitoring as toxicological imputations of azithromycin and its residues in broilers.

Fotouh A, Abdel-Maguid D, Abdelhaseib M, Zaki R, Darweish M Vet World. 2024; 17(6):1271-1280.

PMID: 39077436 PMC: 11283599. DOI: 10.14202/vetworld.2024.1271-1280.


Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats: Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases.

Lappin M, Blondeau J, Boothe D, Breitschwerdt E, Guardabassi L, Lloyd D J Vet Intern Med. 2017; 31(2):279-294.

PMID: 28185306 PMC: 5354050. DOI: 10.1111/jvim.14627.


Nasopharyngeal disease in cats: 2. Specific conditions and their management.

Reed N, Gunn-Moore D J Feline Med Surg. 2012; 14(5):317-26.

PMID: 22511474 PMC: 11132258. DOI: 10.1177/1098612X12444998.


Infectious causes for feline upper respiratory tract disease--a case-control study.

Holst B, Hanas S, Berndtsson L, Hansson I, Soderlund R, Aspan A J Feline Med Surg. 2010; 12(10):783-9.

PMID: 20851008 PMC: 11135524. DOI: 10.1016/j.jfms.2010.06.002.


References
1.
Westfall D, Jensen W, Reagan W, Radecki S, Lappin M . Inoculation of two genotypes of Hemobartonella felis (California and Ohio variants) to induce infection in cats and the response to treatment with azithromycin. Am J Vet Res. 2001; 62(5):687-91. DOI: 10.2460/ajvr.2001.62.687. View

2.
ODair H, Hopper C, Gruffydd-Jones T, Harbour D, Waters L . Clinical aspects of Chlamydia psittaci infection in cats infected with feline immunodeficiency virus. Vet Rec. 1994; 134(15):365-8. DOI: 10.1136/vr.134.15.365. View

3.
Sykes J, Anderson G, Studdert V, Browning G . Prevalence of feline Chlamydia psittaci and feline herpesvirus 1 in cats with upper respiratory tract disease. J Vet Intern Med. 1999; 13(3):153-62. DOI: 10.1892/0891-6640(1999)013<0153:pofpaf>2.3.co;2. View

4.
Studdert M, Studdert V, Wirth H . Isolation of Chlamydia psittaci from cats with conjunctivitis. Aust Vet J. 1981; 57(11):515-7. DOI: 10.1111/j.1751-0813.1981.tb05787.x. View

5.
McDonald M, Willett B, Jarrett O, Addie D . A comparison of DNA amplification, isolation and serology for the detection of Chlamydia psittaci infection in cats. Vet Rec. 1998; 143(4):97-101. DOI: 10.1136/vr.143.4.97. View